Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... to the advancement of biomedical applications of these nanomaterials as imaging or therapeutic agents. The accuracy of current in vitro methods, however, is limited by interanimal ...
2009 NOV 25 ... the unique set of tools we are able to offer our customers".Patents for the therapeutic use of UNA oligonucleotides are held by MDRNA, Inc., Bothell, ... enable the fine-tuning of the duplex thermodynamic stability of oligonucleotides with applications in areas such as improved siRNA gene silencing.Professor Jesper Wengel, ...
2009 NOV 23 ... molecules to identify certain conditions, or dyes to help in medical imaging, or therapeutic agents to remedy a wide-range of afflictions.Already well documented, mNPs ... this week in IOP Publishing's Journal of Physics D: Applied Physics, 'Progress in Applications of Magnetic Nanoparticles in Biomedicine', shows just how far magnetic nanoparticles ...
2009 NOV 23 ... and safety. According to the review, XMT-1001 demonstrated an improved therapeutic window compared to CPT or irinotecan in human tumor xenograft studies. The review also ... 2009 special issue of Advanced Drug Delivery Reviews on Polymer Therapeutics: Clinical Applications and Challenges for Development. The review article, entitled, "XMT-1001, a novel ...
2009 NOV 23 ... that started in 2002 at Ambion, continued at Asuragen and now at Mirna to exploit the therapeutic potential of miRNAs in cancer. Paul brings critical skills to Mirna as it extends beyond ... from other institutions. Mirna scientists, while at Ambion, filed two very broad patent applications in 2004 naming more than 200 miRNAs and their functional roles in a number of different ...
2009 NOV 23 ... of differentially expressed proteins as targets for validating the efficacy of future therapeutic strategies aiming to delay and/or revert the pathologic phenotype of PXE fibroblasts," ... Boraldi and colleagues published their study in Proteomics Clinical Applications (Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin ...
2009 NOV 23 ... of lead compounds. Poorly water-soluble new chemical entities (NCE's) exhibiting therapeutic activity is a major hurdle and can delay and even prevent commercialization. Development ... technologies that will be utilized for pharmaceutical, biotechnology and nutraceutical applications. Enavail is an Emergent Technologies, Inc. (ETI) portfolio company, headed by Dr. Brian ...
2009 NOV 23 ... agents designed for other clinical applications as a means to expedite efforts involving therapeutic translation. Diabetes 58:2277-2284, 2009." Parker and colleagues published ...
2009 NOV 24 ... metabolic markers, such as those associated with thyroid disease, malignant cancers, therapeutic drugs and other medically relevant conditions, as part of its QN Diagnostics initiative ... professional markets (QN Diagnostics); (2) PAD technology for over-the-counter applications, and the diagnosis and treatment of women's health concerns and other medical needs, ...
2009 NOV 23 ... "Lastly, these observations suggest that PRAME is a target for both prognostic and therapeutic applications. (Blood. 2009; 114:3299-3308)." Oehler and colleagues published their ...
2009 NOV 23 ... For additional information, contact H. Mischak, Mosaiques Diagnostic & Therapeutic AG, Mellendorfer Str 7-9, D-30625 Hannover, Germany. The publisher of the ... Mischak and colleagues published their study in Proteomics Clinical Applications (Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity ...
2009 NOV 23 ... "Therapeutic approaches for autoimmune diseases are primarily based on suppressive measures that down ... this review we gather existing information regarding IVIg mechanisms of action, clinical applications and its effects on various conditions." Arnson and colleagues published ...
2009 NOV 27 ... into how the peptide works at a molecular level.In addition to the potential therapeutic applications to NOTCH-dependent cancers, the Nature study also forms the basis of a general strategy ...
2009 NOV 26 ... transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of ... starch production, and has potential as a biofuel source, there are commercial applications of these breeding tools. However, the most important applications will be those that ...
2009 NOV 23 ... adenoviral (Ad) vectors have shown promise as a tool for gene delivery-based therapeutic applications. Their clinical use is however limited by therapeutically suboptimal transduction levels ...
2009 NOV 23 ... in a variety of cardiovascular diseases. We provide an overview and an update of all therapeutic applications of synthetic HDL tested in animal models or in clinical trials," wrote C. Parolini and ...
2009 NOV 24 ... is a naturally present compound in the living system and is the target in therapeutic strategy of Parkinson's disease," scientists in Madras, India ... and 10(-4) M. Thus, DOPA may be a useful stabilizing agent for collagen for biomedical applications."Usha and colleagues published their study in the Journal of Photochemistry ...
2009 NOV 24 ... green (ICG) is a fluorescent probe used in various optically mediated diagnostic and therapeutic applications. However, utility of ICG remains limited by its unstable optical properties and ...
2009 NOV 23 ... new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes. About the NMI The National Microelectronics ... wireless vital signs monitor that delivers real-time, high-quality data for healthcare applications. This month, Toumaz announced that it has begun a landmark clinical trial of its Sensium ...
2009 NOV 23 ... on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, announced financial results for the three and nine months ended ... States Patent and Trademark Office issued a Notice of Allowance for one of our patent applications with claims that cover the use of our low-dose sublingual Intermezzo=AE formulation. ...
